Preclinical characterization of DUOC-01, a cell therapy product derived from banked umbilical cord blood for use as an adjuvant to umbilical cord blood transplantation for treatment of inherited metabolic diseases

BACKGROUND AIMS: Cord blood (CB) transplantation slows neurodegeneration during certain inherited metabolic diseases. However, the number of donor cells in the brain of patients does not appear to be sufficient to provide benefit until several months after transplant. We developed the cell product D...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cytotherapy
Autors principals: KURTZBERG, JOANNE, BUNTZ, SUSAN, GENTRY, TRACY, NOELDNER, PAMELA, OZAMIZ, APRIL, RUSCHE, BENJAMIN, STORMS, ROBERT W., WOLLISH, AMY, WENGER, DAVID A., BALBER, ANDREW E.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4843803/
https://ncbi.nlm.nih.gov/pubmed/25770677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2015.02.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars